ArticleDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy2026

Host-directed novel mechanistic insights of doxorubicin reveal its efficacy against drug-resistant HSV-1 underscoring risks with oncolytic virotherapy.

Pankaj Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.